ShuYun Zhang

Characterization of a Novel PERK Kinase Inhibitor with Antitumor and Antiangiogenic Activity

Charity Atkins, Qi Liu, Elisabeth A. Minthorn et al. · Cancer Research · 2013 · 429 citations

Medicine, Oncology, Pharmacology +14

Antitumor activity of an allosteric inhibitor of centromere-associated protein-E

Kenneth W. Wood, Latesh Lad, Lusong Luo et al. · Proceedings of the National Academy of Sciences · 2010 · 254 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

Identification of 4-(2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-{[(3<i>S</i>)-3-piperidinylmethyl]oxy}-1<i>H</i>-imidazo[4,5-<i>c</i>]pyridin-4-yl)-2-methyl-3-butyn-2-ol (GSK690693), a Novel Inhibitor of AKT Kinase

Dirk A. Heerding, Nelson Rhodes, Jack D. Leber et al. · Journal of Medicinal Chemistry · 2008 · 155 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

Bridging the Gap between Cytotoxic and Biologic Therapy with Metronomic Topotecan and Pazopanib in Ovarian Cancer

William M. Merritt, Alpa M. Nick, Amy R. Carroll et al. · Molecular Cancer Therapeutics · 2010 · 57 citations · Full text

Medicine, Oncology, Pharmacology +17

Aminofurazans as potent inhibitors of AKT kinase

Meagan B. Rouse, Mark A. Seefeld, Jack D. Leber et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 43 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +11